Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Bibeau buys 100,000 shares @ .095

Also, with that in mind, I guess I'd have to agree that nothing "material" has should have happened or is happening with PTSC, or else Bibeau's purchase should be disallowed. Assuming that, do you have any explanation for the invocation of "SEC counsel" language, and this self-imposed quiet period regarding MMP related topics other than PTSC CHOOSING to keep shareholders in the dark yet again?

I thought maybe they were discussing a purchase or sale of the MMP, or perhaps were being sued or were suing regarding the MMP, but based on Bibeau's purchase, and no 10b5-1 on file for him, it seems all of those issues would be off the table. Concur, and any other possiblities you see/suspect? TIA.

Share
New Message
Please login to post a reply